# Comparative antibody and cell-mediated immune responses, reactogenicity, and efficacy of homologous and heterologous boosting with CoronaVac and BNT162b2 (Cobovax): an open-label, randomised trial

> Research article (The Lancet Microbe, 2023) · cited 25× · AI/ML

**Wikidata**: [openalex:W4385568795](https://www.wikidata.org/wiki/openalex:W4385568795)  
**Source**: https://4ort.xyz/entity/comparative-antibody-and-cell-mediated-immune-responses-reactogenicity-and-efficacy-of-homologous-and-heterologous-boost